CNVS.NASDAQCineverse CORP

Form 4: Cineverse CSO Opeka Reports Significant Equity Stake

Sentiment:

Insider Ownership Report

📋All filings for Cineverse CORP
🔒Login to Follow

Cineverse Corp.'s CSO and President, Erick Opeka, filed a Form 4 detailing his beneficial ownership of Class A Common Stock and various derivative securities, including recent RSU acquisitions.

Summary

  • Erick Opeka, CSO and President of Cineverse Corp. (CNVS), reported beneficial ownership of 194,146 shares of Class A Common Stock.
  • This includes 91,667 shares of restricted stock, with 45,833 vesting on April 25, 2026, and 45,834 vesting on April 25, 2027.
  • Opeka holds Stock Appreciation Rights (SARs) for 17,750 shares with an exercise price of $23.2, expiring September 28, 2028, which fully vested by March 31, 2021.
  • Additional SARs for 60,000 shares have an exercise price of $12.8, expiring December 23, 2030, and fully vested by December 31, 2023.
  • Further SARs for 75,000 shares have an exercise price of $5.8, expiring May 16, 2033, with vesting scheduled for May 16, 2024, May 1, 2025, and May 1, 2026.
  • He also holds 91,667 Restricted Stock Units (RSUs) vesting on April 25, 2026, and April 25, 2027.
  • Another 94,550 RSUs are held, vesting on May 1 of 2026, 2027, and 2028.
  • On October 8, 2025, Opeka acquired 144,147 Restricted Stock Units (RSUs) at a price of $0, which will vest in three equal installments on October 8 of 2026, 2027, and 2028.

Sentiment

Score: 7

Explanation: The filing indicates an executive's continued acquisition of equity and derivative securities, suggesting confidence in the company's future and strong alignment with shareholder interests. This is generally a positive signal.

Positives

  • The acquisition of 144,147 Restricted Stock Units (RSUs) by a key executive indicates continued commitment and alignment of management interests with long-term shareholder value.
  • Significant holdings of both common stock and derivative securities demonstrate a substantial personal stake in the company's performance.
  • The structured vesting schedules for RSUs and SARs provide long-term incentives for the executive to contribute to sustained growth and profitability.

Stakeholder Impact

  • Shareholders: Increased executive ownership and long-term incentives can signal management's confidence, potentially positively influencing investor sentiment and aligning executive interests with shareholder returns.

Next Steps

  • Vesting of 25,000 Stock Appreciation Rights (SARs) on May 16, 2024.
  • Vesting of 25,000 Stock Appreciation Rights (SARs) on May 1, 2025.
  • Vesting of 45,833 shares of restricted stock and 45,833 Restricted Stock Units (RSUs) on April 25, 2026.
  • Vesting of 25,000 Stock Appreciation Rights (SARs) and 31,517 Restricted Stock Units (RSUs) on May 1, 2026.
  • Vesting of one-third of the 144,147 Restricted Stock Units (RSUs) on October 8, 2026.
  • Vesting of 45,834 shares of restricted stock and 45,834 Restricted Stock Units (RSUs) on April 25, 2027.
  • Vesting of 31,517 Restricted Stock Units (RSUs) on May 1, 2027.
  • Vesting of one-third of the 144,147 Restricted Stock Units (RSUs) on October 8, 2027.
  • Vesting of 31,516 Restricted Stock Units (RSUs) on May 1, 2028.
  • Expiration of Stock Appreciation Rights (SARs) with $23.2 exercise price on September 28, 2028.
  • Vesting of one-third of the 144,147 Restricted Stock Units (RSUs) on October 8, 2028.
  • Expiration of Stock Appreciation Rights (SARs) with $12.8 exercise price on December 23, 2030.
  • Expiration of Stock Appreciation Rights (SARs) with $5.8 exercise price on May 16, 2033.

Key Dates

DateDescription
March 31, 2019One-third of Stock Appreciation Rights (SARs) with $23.2 exercise price vested.
March 31, 2020One-third of Stock Appreciation Rights (SARs) with $23.2 exercise price vested.
March 31, 2021One-third of Stock Appreciation Rights (SARs) with $23.2 exercise price vested.
March 31, 202225,000 Stock Appreciation Rights (SARs) with $12.8 exercise price vested.
March 31, 202325,000 Stock Appreciation Rights (SARs) with $12.8 exercise price vested.
December 31, 202310,000 Stock Appreciation Rights (SARs) with $12.8 exercise price vested.
May 16, 202425,000 Stock Appreciation Rights (SARs) with $5.8 exercise price vest.
May 1, 202525,000 Stock Appreciation Rights (SARs) with $5.8 exercise price vest.
October 8, 2025Acquisition date for 144,147 Restricted Stock Units (RSUs).
October 10, 2025Signature date of the reporting person.
April 25, 202645,833 shares of restricted stock and 45,833 Restricted Stock Units (RSUs) vest.
May 1, 202625,000 Stock Appreciation Rights (SARs) with $5.8 exercise price vest. Also, 31,517 Restricted Stock Units (RSUs) vest.
October 8, 2026One-third of the 144,147 Restricted Stock Units (RSUs) acquired on 10/08/2025 vest.
April 25, 202745,834 shares of restricted stock and 45,834 Restricted Stock Units (RSUs) vest.
May 1, 202731,517 Restricted Stock Units (RSUs) vest.
October 8, 2027One-third of the 144,147 Restricted Stock Units (RSUs) acquired on 10/08/2025 vest.
May 1, 202831,516 Restricted Stock Units (RSUs) vest.
September 28, 2028Expiration date for Stock Appreciation Rights (SARs) with $23.2 exercise price.
October 8, 2028One-third of the 144,147 Restricted Stock Units (RSUs) acquired on 10/08/2025 vest.
December 23, 2030Expiration date for Stock Appreciation Rights (SARs) with $12.8 exercise price.
May 16, 2033Expiration date for Stock Appreciation Rights (SARs) with $5.8 exercise price.

Keywords

Cineverse, CNVS, Form 4, Insider Ownership, Erick Opeka, Restricted Stock Units, Stock Appreciation Rights, Executive Compensation, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.